Literature DB >> 24062901

Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study.

Uwe Zeymer1, Kurt Huber, Yuling Fu, Allan Ross, Christopher Granger, Patrick Goldstein, Frans van de Werf, Paul Armstrong.   

Abstract

BACKGROUND: Early restoration of blood flow of the infarct-related artery is associated with an improved outcome in patients with ST-elevation myocardial infarction (STEMI). Previous studies have shown a low mortality in patients with TIMI 3 flow before primary percutaneous coronary intervention (PCI). Most likely these patients had spontaneous recanalization of the infarct vessel and might constitute a low-risk subgroup. The purpose of the present analysis was to investigate whether TIMI 3 flow obtained with fibrinolysis before PCI is associated with a clinical outcome comparable to that in patients with spontaneous TIMI 3 flow.
METHODS: Patients with STEMI <6 hours enrolled in the ASSENT-4 PCI study were randomized to facilitated PCI with tenecteplase or primary PCI. For this analysis, patients were divided into three groups according to the TIMI flow of the infarct vessel before PCI: TIMI 0/1, TIMI 2, and TIMI 3.
RESULTS: From a total of 1617 patients, 861 had TIMI 0/1, 279 had TIMI 2, and 477 TIMI 3 flow. The rates of TIMI 3 flow after PCI were 84.6, 89.7, and 95.6%, respectively. Complete ST resolution was observed most often in the TIMI 3 flow group (47.5, 53.6, and 58.6%). The incidence of cardiogenic shock (6.2, 5.5, and 3.6%) and 90-day mortality (6.1, 4.7, and 4.0%) were lowest in the group with TIMI 3 patency before PCI, respectively. The rate of TIMI 3 flow before PCI was higher in the facilitated PCI group than in the primary PCI group (43.9 vs. 15.2%). The 90-day mortality in patients with TIMI 3 before PCI was identical in the facilitated and the primary PCI groups (14/353, 4.0% vs. 5/124, 4.0%).
CONCLUSION: In this post-hoc analysis of ASSENT-4 PCI, TIMI grade 3 flow in the infarct-related artery before PCI, occurring either spontaneously or obtained by fibrinolysis, is associated with a higher TIMI patency after PCI, better improved ST resolution and a trend towards a favourable clinical outcome after 90 days.

Entities:  

Keywords:  Facilitated PCI; ST-elevation myocardial infarction; patency; primary percutaneous coronary intervention

Year:  2012        PMID: 24062901      PMCID: PMC3760529          DOI: 10.1177/2048872612447069

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  18 in total

1.  Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction.

Authors:  Michael D Miedema; Marc C Newell; Sue Duval; Ross F Garberich; Chauncy B Handran; David M Larson; Steven Mulder; Yale L Wang; Daniel L Lips; Timothy D Henry
Journal:  Circulation       Date:  2011-09-19       Impact factor: 29.690

2.  Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.

Authors: 
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321

3.  Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay.

Authors:  Ton Heestermans; Menko-Jan de Boer; Jochem W van Werkum; Arend Mosterd; A T Marcel Gosselink; Jan-Henk E Dambrink; Gert van Houwelingen; Petra Koopmans; Christian Hamm; Felix Zijlstra; Jurriën M ten Berg; Arnoud W J van 't Hof
Journal:  EuroIntervention       Date:  2011-08       Impact factor: 6.534

Review 4.  Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

Authors:  Bernard J Gersh; Gregg W Stone; Harvey D White; David R Holmes
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

5.  Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial.

Authors:  Uwe Zeymer; Hans-Richard Arntz; Bernd Mark; Stephan Fichtlscherer; Gerald Werner; Ralph Schöller; Ralf Zahn; Frank Diller; Harald Darius; Thorsten Dill; Kurt Huber
Journal:  Clin Res Cardiol       Date:  2011-12-21       Impact factor: 5.460

6.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

7.  Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance.

Authors:  Giuseppe Tarantini; Luisa Cacciavillani; Francesco Corbetti; Angelo Ramondo; Martina Perazzolo Marra; Enrico Bacchiega; Massimo Napodano; Claudio Bilato; Renato Razzolini; Sabino Iliceto
Journal:  J Am Coll Cardiol       Date:  2005-10-04       Impact factor: 24.094

8.  Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study.

Authors:  R Schröder; U Zeymer; K Wegscheider; K L Neuhaus
Journal:  Eur Heart J       Date:  1999-11       Impact factor: 29.983

Review 9.  Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models.

Authors:  K A Reimer; R S Vander Heide; V J Richard
Journal:  Am J Cardiol       Date:  1993-12-16       Impact factor: 2.778

Review 10.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

View more
  8 in total

Review 1.  The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool.

Authors:  Yochai Birnbaum; Jani Rankinen; Hani Jneid; Dan Atar; Kjell Nikus
Journal:  Curr Cardiol Rep       Date:  2022-01-13       Impact factor: 2.931

2.  Proximal culprit lesion and coronary artery occlusion independently predict the risk of microvascular obstruction in acute myocardial infarction.

Authors:  N Abanador-Kamper; L Kamper; V Karamani; P Haage; M Seyfarth
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-02       Impact factor: 2.357

Review 3.  Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation.

Authors:  Ying X Gue; Diana A Gorog
Journal:  Int J Mol Sci       Date:  2017-08-25       Impact factor: 5.923

4.  Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.

Authors:  Jing Li; Ying Zhou; Yaowen Zhang; Jingang Zheng
Journal:  BMC Cardiovasc Disord       Date:  2018-06-25       Impact factor: 2.298

5.  Association of culprit lesion plaque characteristics with flow restoration post-fibrinolysis in ST-segment elevation myocardial infarction: an intravascular ultrasound-virtual histology study.

Authors:  Raghavendra Rao K; Sreenivas Reddy; Jeet Ram Kashyap; Vadivelu Ramalingam; Debabrata Dash; Vikas Kadiyala; Suraj Kumar; Hithesh Reddy; Jaspreet Kaur; Ashok Kumar; Naindeep Kaur; Anish Gupta
Journal:  Egypt Heart J       Date:  2020-12-09

6.  Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction.

Authors:  Muhammad Hussain; Rajesh Kumar; Ali Ammar; Syed Alishan; Atif S Muhammad; Fawad Farooq; Tahir Saghir; Naveedullah Khan; Syed N Hassan Rizvi; Tariq Ashraf
Journal:  Cureus       Date:  2020-12-12

7.  Association of coronary artery dominance and mortality rate and complications in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Amir Mikaeilvand; Ata Firuozi; Hosseinali Basiri; Aida Varghaei; Peyman Izadpanah; Javad Kojuri; Alireza Abdi-Ardekani; Armin Attar
Journal:  J Res Med Sci       Date:  2020-11-26       Impact factor: 1.852

8.  Oxidative stress and its association with ST resolution and clinical outcome measures in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention.

Authors:  Elmira Matin; Samad Ghaffari; Alireza Garjani; Neda Roshanravan; Somaieh Matin; Naimeh Mesri Alamdari; Naser Safaie
Journal:  BMC Res Notes       Date:  2020-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.